ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,483.47
      -0.36%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Aston Martin Np (AMLN)

      7. Aston Martin Np (AMLN) News

      AMLN

      Aston Martin Np (AMLN)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AMLN
      DateTimeSourceHeadlineSymbolCompany
      11/04/20104:05PMPR Newswire (US)Amylin Pharmaceuticals Reports Third Quarter Financial ResultsNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      11/03/20108:09AMDow Jones NewsAmylin CEO: Company Can Withstand Diabetes-Drug SetbackNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/29/201011:59AMDow Jones NewsVivus Sees Pathway To 2011 Approval For Rejected Diet DrugNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/28/20104:05PMPR Newswire (US)Amylin Pharmaceuticals to Webcast Third Quarter ResultsNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/27/201011:03AMMarketwiredWall Street News Alert: Mid-Morning Stock Watch: Unity Management Group -- October 27, 2010NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/27/20109:28AMDow Jones News3rd UPDATE: Novo Nordisk Raises Outlook As Diabetes Sales RiseNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/27/20104:53AMDow Jones News2nd UPDATE: Novo Nordisk Raises Outlook As Diabetes Sales RiseNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/27/20103:30AMDow Jones NewsUPDATE: Novo Nordisk Lifts Outlook As Diabetes Sales RiseNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/22/201012:56PMDow Jones NewsDenmark's Zealand Pharma Set For Nov Partial Listing - SourceNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/21/20105:01PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/21/20101:34PMDow Jones News2nd UPDATE:Lilly 3Q Net Up 38% After '09 Charges; EPS View RaisedNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/21/20101:33PMDow Jones NewsCORRECT: UPDATE: Lilly 3Q Net Jumps 38% After 2009 Charges; EPS View RaisedNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/21/201010:03AMDow Jones NewsUPDATE: Lilly 3Q Net Jumps 38% After 2009 Charges; EPS View RaisedNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/19/20109:46PMDow Jones News2nd UPDATE: FDA Again Denies Approval For Long-Acting ByettaNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/19/20108:13PMDow Jones NewsUPDATE: FDA Requests Heart-Rate Test For Amylin, Eli, Alkermes Diabetes DrugNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/19/20107:39PMDow Jones NewsFDA Requests Heart-Rate Test For Amylin, Eli, Alkermes Diabetes DrugNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/19/20107:06PMPR Newswire (US)Amylin Pharmaceuticals Announces Third Quarter Product Revenues; Quarterly Update Conference Call CanceledNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/19/20106:40PMPR Newswire (US)Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/15/20104:13PMDow Jones NewsDiabetes Drug's Approval Expected, But Impact Still UncertainNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/13/20104:15PMPR Newswire (US)Amylin Pharmaceuticals to Webcast Third Quarter ResultsNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/13/201012:01PMDow Jones NewsAlkermes Gets Vivitrol Approval, Investors Focus ElsewhereNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/12/20107:36PMDow Jones NewsAlkermes: FDA Widens Approved Use Of Vivitrol For Opioid AddictionNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/05/20105:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/05/20105:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/05/20105:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      10/05/20105:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      09/30/20104:33AMDow Jones NewsSanofi Reports Good Diabetes Drug Results Ahead Of R&D DayNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      09/14/20104:30PMPR Newswire (US)BYETTA® and BYDUREON™ to be Featured in More Than a Dozen Study Presentations at EASD 2010NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      09/08/20108:34AMDow Jones NewsBioMed Realty Trust Acquiring San Diego Portfolio For $132.9 MillionNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
      09/07/20108:00AMPR Newswire (US)Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare and Baird Global Healthcare ConferencesNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
       Showing the most relevant articles for your search:NASDAQ:AMLN